Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
14.18
-0.80 (-5.34%)
At close: Feb 21, 2025, 4:00 PM
14.29
+0.11 (0.78%)
After-hours: Feb 21, 2025, 7:30 PM EST
Myriad Genetics Analyst Ratings
Total Analysts
13
Consensus Rating
Hold
Price Target
$22.54
Upside
+58.96%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $29 | Strong Buy | Initiates | $29 | +104.51% | Feb 12, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $24 → $14 | Hold | Maintains | $24 → $14 | -1.27% | Jan 30, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $29 → $18 | Strong Buy | Maintains | $29 → $18 | +26.94% | Jan 28, 2025 |
| Stephens & Co. | Stephens & Co. | Hold Reiterates $20 | Hold | Reiterates | $20 | +41.04% | Jan 16, 2025 |
| B of A Securities | B of A Securities | Sell Maintains $15 → $13 | Sell | Maintains | $15 → $13 | -8.32% | Dec 13, 2024 |
| UBS | UBS | Hold Initiates $18 | Hold | Initiates | $18 | +26.94% | Dec 10, 2024 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $30 → $21 | Buy → Hold | Downgrades | $30 → $21 | +48.10% | Dec 9, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $32 → $21 | Hold | Maintains | $32 → $21 | +48.10% | Nov 18, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $30 → $24 | Hold | Maintains | $30 → $24 | +69.25% | Nov 11, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Initiates $32 | Hold | Initiates | $32 | +125.67% | Sep 19, 2024 |
| Wells Fargo | Wells Fargo | Buy Initiates $35 | Buy | Initiates | $35 | +146.83% | Aug 27, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $29 → $34 | Buy | Maintains | $29 → $34 | +139.77% | Aug 13, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $28 → $30 | Hold | Maintains | $28 → $30 | +111.57% | Aug 13, 2024 |
| TD Cowen | TD Cowen | Hold Maintains $28 → $30 | Hold | Maintains | $28 → $30 | +111.57% | Aug 7, 2024 |
| JP Morgan | JP Morgan | Sell Maintains $17 → $20 | Sell | Maintains | $17 → $20 | +41.04% | Aug 7, 2024 |
| Scotiabank | Scotiabank | Buy Initiates $29 | Buy | Initiates | $29 | +104.51% | Jun 27, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.